Evidence map›Paper›PMID 39642883›Full record

ArticleMolecular cell2025

GABA

Yueyue Wang, Yalan Zhang, Wenxue Li, Barbora Salovska, Jianan Zhang, Tongqing Li, Hengyi Li, Yansheng Liu, Leonard K Kaczmarek, Lajos Pusztai and 1 more

Abstract read
In one paragraph

Article in Molecular cell, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Yueyue WangYale Cancer Biology Institute, Yale University, West Haven, CT 06516, USA; Breast Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.
Yalan ZhangDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Wenxue LiYale Cancer Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Barbora SalovskaYale Cancer Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Jianan ZhangYale Cancer Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Tongqing LiYale Cancer Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Hengyi LiYale Cancer Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Yansheng LiuYale Cancer Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA; Department of Biomedical Informatics & Data Science, Yale University School of Medicine, New Haven, CT 06510, USA.
Leonard K KaczmarekDepartment of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA.
Lajos PusztaiBreast Medical Oncology, Yale Cancer Center, Yale University School of Medicine, New Haven, CT 06520, USA.
Daryl E KleinYale Cancer Biology Institute, Yale University, West Haven, CT 06516, USA; Department of Pharmacology, Yale University School of Medicine, New Haven, CT 06520, USA. Electronic address: daryl.klein@yale.edu.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
Understanding how membrane composition directs membrane protein structure and functionRM1GM149406 · NIGMS · YALE UNIVERSITY · PI Joel Adam Butterwick, KATHRYN M FERGUSON · 2023 to 2026
$8.4M
Cellular Regulation of Sodium-activated Potassium ChannelsR01NS102239 · NINDS · YALE UNIVERSITY · PI LEONARD K KACZMAREK · 2018 to 2026
$3.5M
Understanding proteome remodeling in aneuploidyR01GM137031 · NIGMS · YALE UNIVERSITY · PI LIU, YANSHENG · 2020 to 2024
$2.0M
NCATS NIH HHS UL1 TR001863NIGMS NIH HHS R01 GM137031NIGMS NIH HHS RM1 GM149406NINDS NIH HHS R01 NS102239
6 · The paper itself

Abstract

The rare γ-aminobutyric acid type-A receptor (GABA

Indexed as

Cryoelectron MicroscopyExtracellular Signal-Regulated MAP Kinasesgamma-Aminobutyric AcidReceptors, GABA-AHEK293 CellsHumansMAP Kinase Signaling SystemSignal TransductionExtracellular Signal-Regulated MAP KinasesGABRP protein, humangamma-Aminobutyric AcidReceptors, GABA-Aantibodybreast cancercancerERKGABAGABA(A) receptor πGABA type-A receptorGABRPMAPKtherapeuticsTNBC

Identifiers

PMID39642883
PMCPMC11698630

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.